Key Takeaways
- Shares of Palantir closed 2% lower at $131.94 on Tuesday, marking a 26% decline year-to-date in 2026 and a 36% pullback from its November 2025 peak of $207.18.
- Wolfe Research raised its rating on PLTR from Underperform to Peer Perform without establishing a specific price target.
- Analysts at Wolfe praised Palantir as “the most applied enterprise AI software company” while cautioning that its valuation remains “the most expensive in software.”
- UBS reaffirmed its Buy rating with a $200 target despite growing questions about competitive pressure from OpenAI, Anthropic, and Databricks.
- Among 32 Wall Street analysts monitored by FactSet, PLTR maintains an average Overweight rating with a consensus target of $189.87, suggesting 44% potential gains.
Palantir Technologies (PLTR) received a rating boost from Wolfe Research on Tuesday. Shares declined anyway.
The market reaction speaks volumes about current investor psychology surrounding the stock.
Palantir Technologies Inc., PLTR
Shares closed at $131.94 on Tuesday, continuing a challenging period that has erased 26% of the stock’s value in 2026. The decline accelerated in June with a 16% drop, leaving PLTR trading 36% beneath its all-time closing peak of $207.18 reached on November 3, 2025.
Meanwhile, broader market indexes have performed significantly better, with the S&P 500 climbing 10% year-to-date and the Nasdaq Composite advancing approximately 14%.
Analysts Alex Zukin and Joshua Tilton at Wolfe Research reinstated coverage of PLTR with a Peer Perform designation, an improvement from their previous Underperform stance. The analysts chose not to include a specific price objective with their recommendation.
Their assessment presents a nuanced perspective. While they recognize Palantir as the premier applied enterprise AI software provider boasting the sector’s strongest growth metrics, they simultaneously highlight that the stock’s present valuation “is still the most expensive in software.”
PLTR currently commands a forward price-to-earnings multiple of approximately 77.4 times, substantially above the S&P 500’s 21.07 times ratio.
“We love the business,” Zukin stated, “and if growth trends closer to our upside scenario we could find ourselves looking at an entry point too good to ignore.” However, the firm believes the existing premium already incorporates much of the anticipated growth and margin expansion.
The Ontology Advantage
The Wolfe analysts highlighted Palantir’s Ontology platform as its primary competitive advantage. This proprietary system integrates AI with human decision-making processes to streamline enterprise operations. Zukin observed that Ontology revenue and pipeline commitments are gaining momentum in 2026, viewing this as an encouraging indicator.
Earlier the same day, UBS analyst Karl Keirstead published commentary maintaining a Buy recommendation alongside a $200 price objective. Keirstead held firm on his outlook following discussions with Palantir leadership that centered primarily on competitive dynamics.
Rivalry Considerations
The primary concern raised by investors during the UBS meeting involved whether competitors such as OpenAI, Anthropic, and Databricks — all currently building field deployment capabilities and data integration frameworks — might undermine Palantir’s ontology advantage.
Palantir management countered these concerns, asserting that its operating platform extends far beyond basic large language model deployment or data ingestion. Company representatives expressed skepticism that LLM providers would achieve significant traction in the data infrastructure space.
Palantir maintains an 84% gross profit margin, which UBS highlighted as confirmation of strong pricing authority and market positioning.
According to InvestingPro data, 21 analysts have recently increased their earnings projections for the company.
Additional recent analyst activity includes Rosenblatt reaffirming a Buy rating following client acquisition announcements and a Google Cloud collaboration unveiled at AIPCon 10. Baird similarly sustained an Outperform designation with a $200 target following proprietary investor discussions with Palantir executives.
The United Kingdom government disclosed plans to conduct a review of Palantir’s arrangement with the National Health Service.
Across 32 research firms monitored by FactSet, PLTR holds an average Overweight recommendation with a consensus price objective of $189.87, implying 44% upside potential from present trading levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
